News about "Dapagliflozin "

Lupin Launches Diabetes Drug Combination in the US

Lupin Launches Diabetes Drug Combination in the US

Lupin launches dapagliflozin and metformin extended-release tablets in the US, offering a bioequivalent and cost-effective alternative for type 2 diabetes management.

Dapagliflozin | 22/04/2026 | By News Bureau

Lupin Secures US FDA Approval for Dapagliflozin Tablets in US

Lupin Secures US FDA Approval for Dapagliflozin Tablets in US

Lupin secures US FDA approval for Dapagliflozin Tablets 5 mg and 10 mg in the US, bioequivalent to Farxiga.

Dapagliflozin | 08/04/2026 | By News Bureau

Lupin Gets Tentative Approval from U.S. FDA for Dapagliflozin and Saxagliptin Tablets

Lupin Gets Tentative Approval from U.S. FDA for Dapagliflozin and Saxagliptin Tablets

Dapagliflozin and Saxagliptin Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Dapagliflozin | 05/01/2024 | By Manvi 531


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members